Opendata, web and dolomites

LysoMod SIGNED

Genetic and Small Molecule Modifiers of Lysosomal Function

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LysoMod project word cloud

Explore the words cloud of the LysoMod project. It provides you a very rough idea of what is the project "LysoMod" about.

transfer    generation    private    age    proteomics    lysosomal    human    linked    therapies    diseases    staff    optimize    lsds    trials    companies    therapeutic    pharmacology    approved    collaborative    complementary    expertise    quality    lysosomes    exploring    biology    biomedical    multidisciplinary    action    biological    cell    storage    training    either    sectors    modifier    medicine    young    dysfunction    led    personalized    drugs    strategies    life    ranging    people    pathology    genes    prioritising    candidate    mechanisms    play    neurodegenerative    clinical    critical    lysomod    public    mouse    health    biochemistry    mentored    chemistry    lipidomics    disorders    rapid    genetics    drug    area    expression    rnas    exchange    talk    disorder    signalling    preparing    gene    cross    lsd    diagnostics    pioneer    cells    regulation    innovative    participant    variety    lysosome    academic    innovate    function    medicinal    careers    transcriptomics    implementing   

Project "LysoMod" data sheet

The following table provides information about the project.

Coordinator
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES 

Organization address
address: AVENIDA PROF EGAS MONIZ
city: LISBOA
postcode: 1649 028
website: www.imm.ul.pt

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website https://lysomod.wixsite.com/lysomod
 Total cost 1˙156˙500 €
 EC max contribution 1˙102˙500 € (95%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2016
 Funding Scheme MSCA-RISE
 Starting year 2017
 Duration (year-month-day) from 2017-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) coordinator 366˙300.00
2    GENOMED, DIAGNOSTICOS DE MEDICINA MOLECULAR SA PT (LISBOA) participant 240˙750.00
3    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 198˙000.00
4    INSTITUTUL DE BIOCHIMIE RO (BUCHAREST) participant 130˙500.00
5    CHRONOS BIOSYSTEMS SRL RO (Bucharest) participant 108˙000.00
6    INTRABIO LTD UK (LONDON) participant 27˙000.00
7    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) participant 18˙450.00
8    THE UNIVERSITY OF SUSSEX UK (BRIGHTON) participant 13˙500.00
9    FONDAZIONE TELETHON IT (ROMA) participant 0.00
10    LIPOTYPE DE (DRESDEN) participant 0.00
11    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE CL (SANTIAGO) partner 0.00
12    THE CHILDREN'S HOSPITAL OF PHILADELPHIA NON PROFIT ORG US (Philadelphia) partner 0.00
13    UNIVERSIDAD DE BUENOS AIRES AR (BUENOS AIRES) partner 0.00
14    UNIVERSIDAD DEL DESARROLLO CL (SAN CARLOS DE APOQUINDO) partner 0.00

Map

 Project objective

LysoMod will innovate in the area of personalized medicine for disorders linked to lysosomal dysfunction. This will be achieved by implementing a collaborative staff-exchange program between highly complementary and multidisciplinary academic and non-academic partners with expertise in pharmacology, medicinal chemistry, cell biology, biochemistry, mouse and human genetics, transcriptomics, proteomics and lipidomics. Based on the critical role that lysosomes play in cells, a better understanding of lysosomal function will have a major impact on human health, fostering the development of new strategies to improve quality of life for people affected by a variety of diseases, ranging from lysosomal storage diseases (LSDs) to age-related neurodegenerative disorders. LysoMod’s specific objectives are: 1) to develop and further optimize existing therapies for LSDs; 2) to identify new targets for personalized therapies for LSDs; and 3) to investigate the cross-talk between lysosomal function, signalling pathways and gene expression regulation. The pioneer work of a participant in the consortium led to the development of a drug that is approved for clinical use. LysoMod will i) investigate the mechanisms of action of this and other drugs in lysosome-related disorder; ii) identify modifier genes involved in LSD pathology and test their potential as new targets for personalized therapeutic approaches; iii) identify candidate RNAs that can be targeted to enhance lysosomal function. The companies in the consortium will ensure a rapid transfer of new knowledge into applications for diagnostics and clinical trials. Prioritising lysosomal dysfunction as a highly relevant biomedical problem, the LysoMod consortium will implement a mentored staff-exchange program to provide young researchers with high-level training in innovative approaches for exploring biological systems, preparing the next generation of researchers for careers either in the private or public health sectors.

 Deliverables

List of deliverables.
Organization of a summer school in Chile Other 2020-03-03 15:05:06
Project Website Internet-based social media Websites, patent fillings, videos etc. 2020-03-03 15:05:06

Take a look to the deliverables list in detail:  detailed list of LysoMod deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYSOMOD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LYSOMOD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

FUNGLASS (2019)

FUNctional GLASS

Read More  

aiD (2019)

aRTIFICIAL iNTELLIGENCE for the Deaf

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More